Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 4:53 PM ET

Healthcare Equipment and Supplies

Company Overview of AngioScore, Inc.

Company Overview

AngioScore, Inc. designs, manufactures, and markets endovascular tools to treat cardiovascular and peripheral artery diseases. It offers AngioSculpt Scoring Balloon Catheter for the treatment of simple to complex coronary lesions, including in-stent restenosis and type C lesions; and treatment of peripheral artery diseases that address a range of peripheral lesions, including long diffuse lesions found in infrainguinal arteries. The company also provides AngioSculpt PTA Scoring Balloon Catheter for dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, infra popliteal, and renal arteries, as well as for the treatment of obstructive lesions of native or synthetic arteriovenous ...

5055 Brandin Court

Fremont, CA 94538

United States

Founded in 2003





Key Executives for AngioScore, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 67
Senior Vice President of Operations
Age: 55
Managing Director of International Business
Senior Vice President of Regulatory & Quality
Senior Vice President of U.S. Commercial Sales
Compensation as of Fiscal Year 2015.

AngioScore, Inc. Key Developments

AngioScore Launches New 200 mm Length AngioSculpt Scoring Balloon Catheters

AngioScore, Inc. launched its new 200 mm length AngioSculpt(R) PTA Scoring Balloon Catheters for the treatment of Peripheral Artery Disease (PAD) above-the-knee (ATK). The new AngioSculpt catheters received U.S. Food and Drug Administration (FDA) 510(k) clearance to be marketed for the dilatation of lesions in the iliac, femoral, iliofemoral, popliteal, infra-popliteal, and renal arteries, and to treat obstructive lesions of native or synthetic arteriovenous dialysis fistulae. They are not approved for use in the coronary or neuro-vasculature. The catheters incorporate 200 mm balloons in diameters of 4.0, 5.0 and 6.0 mm with a novel scoring element specifically designed for these longer balloons. The devices are expected to be particularly useful in treating the typical complex and long lesions found above-the-knee. The AngioSculpt balloon catheter was developed by AngioScore, Inc., which was acquired June 30, 2014, by The Spectranetics Corporation.

The Spectranetics Corporation, AngioScore, Inc. - M&A Call

To discuss merger agreement under which The Spectranetics Corporation will acquire AngioScore Inc

AngioScore, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 11:30 AM

AngioScore, Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 11:30 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Thomas R. Trotter, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
Vasacraft, LLC United States
Doctors Research Group, Inc. United States
Imaging Sciences International, Inc. United States
Infrared Sciences Corp. United States
Coagusense, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AngioScore, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at